These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33078634)

  • 1. An overview of carbohydrate-based carbonic anhydrase inhibitors.
    Cuffaro D; Nuti E; Rossello A
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1906-1922. PubMed ID: 33078634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer.
    Winum JY; Colinas PA; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1419-26. PubMed ID: 23199483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of glycosidic carbonic anhydrase inhibitors.
    Winum JY; Poulsen SA; Supuran CT
    Med Res Rev; 2009 May; 29(3):419-35. PubMed ID: 19058143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
    Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
    Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
    Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors.
    Martínez-Montiel M; Romero-Hernández LL; Giovannuzzi S; Begines P; Puerta A; Ahuja-Casarín AI; Fernandes MX; Merino-Montiel P; Montiel-Smith S; Nocentini A; Padrón JM; Supuran CT; Fernández-Bolaños JG; López Ó
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New zinc binding motifs in the design of selective carbonic anhydrase inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Mini Rev Med Chem; 2006 Aug; 6(8):921-36. PubMed ID: 16918498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
    Mishra CB; Tiwari M; Supuran CT
    Med Res Rev; 2020 Nov; 40(6):2485-2565. PubMed ID: 32691504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversely
    Angeli A; Ferraroni M; Bonardi A; Supuran CT; Nocentini A
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2178430. PubMed ID: 36798036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
    De Luca L; Mancuso F; Ferro S; Buemi MR; Angeli A; Del Prete S; Capasso C; Supuran CT; Gitto R
    Eur J Med Chem; 2018 Jan; 143():276-282. PubMed ID: 29197732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors.
    Nocentini A; Moi D; Deplano A; Osman SM; AlOthman ZA; Balboni G; Supuran CT; Onnis V
    Eur J Med Chem; 2020 Jan; 186():111896. PubMed ID: 31784185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
    Lopez M; Bornaghi LF; Innocenti A; Vullo D; Charman SA; Supuran CT; Poulsen SA
    J Med Chem; 2010 Apr; 53(7):2913-26. PubMed ID: 20201556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.
    Vitale RM; Alterio V; Innocenti A; Winum JY; Monti SM; De Simone G; Supuran CT
    J Med Chem; 2009 Oct; 52(19):5990-8. PubMed ID: 19731956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
    Guler OO; De Simone G; Supuran CT
    Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives.
    Ciccone L; Cerri C; Nencetti S; Orlandini E
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products that inhibit carbonic anhydrase.
    Poulsen SA; Davis RA
    Subcell Biochem; 2014; 75():325-47. PubMed ID: 24146386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
    Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments of small molecules as inhibitors for carbonic anhydrase isoforms.
    Buabeng ER; Henary M
    Bioorg Med Chem; 2021 Jun; 39():116140. PubMed ID: 33905966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.